Please ensure Javascript is enabled for purposes of website accessibility

drug manufacturing

Feb 4, 2026

Eli Lilly reporting strong fiscal performance

Eli Lilly reported strong 2025 financials and forecast up to $83B in 2026 revenue as it prepares to build a $3.5B Lehigh Valley facility.